Navigation Links
Xeomin® (incobotulinumtoxinA) Data To Be Presented At The 71st Annual Assembly Of The American Academy Of Physical Medicine And Rehabilitation
Date:11/5/2010

(anaphylaxis, serum sickness, urticaria, soft tissue edema, and dyspnea). If serious and/or immediate hypersensitivity reactions occur further injection of XEOMIN should be discontinued and appropriate medical therapy immediately instituted.
  • Treatment with XEOMIN and other botulinum toxin products can result in swallowing or breathing difficulties. Patients with pre-existing swallowing or breathing difficulties may be more susceptible to these complications. In most cases, this is a consequence of weakening of muscles in the area of injection that are involved in breathing or swallowing. When distant effects occur, additional respiratory muscles may be involved [See Boxed Warning]. Deaths as a complication of severe dysphagia have been reported after treatment with botulinum toxin. Dysphagia may persist for several months, and require use of a feeding tube to maintain adequate nutrition and hydration. Aspiration may result from severe dysphagia and is a particular risk when treating patients in whom swallowing or respiratory function is already compromised. These reactions can occur within hours to weeks after injection with botulinum toxin.
  • Cervical Dystonia: Patients with smaller neck muscle mass and patients who require bilateral injections into the sternocleidomastoid muscles are at greater risk of dysphagia. Limiting the dose injected into the sternocleidomastoid muscle may decrease the occurrence of dysphagia.
  • Blepharospasm:  Injection of XEOMIN into the orbicularis oculi muscle may lead to reduced blinking and corneal exposure with possible ulceration or perforation. Lower lid injections should not be repeated if diplopia occurred with previous botulinum toxin injections.
  • Individuals with peripheral motor neuropathic diseases, amyotrophic lateral sclerosis, or neuromuscular junctional disorders (e.g., myasthenia gravis or Lambert-Eaton syndrome) should be monitored particularly closely when given botul
    '/>"/>

  • SOURCE Merz Pharmaceuticals
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Xeomin® (incobotulinumtoxinA) - a Botulinum Toxin Free From Accessory Proteins - Now Available in the U.S.
    2. FDA Approves Merz Pharmaceuticals Xeomin® (incobotulinumtoxinA) for the Treatment of Cervical Dystonia and Blepharospasm
    3. Romark Announces Data Presented at AASLD Meeting 2010
    4. Medivir Notes That Partner Tibotec Announced Week 24 Interim Results From Phase 2b TMC435 PILLAR Study to be Presented as a Late-Breaker at AASLD
    5. ANA598 Data Presented at AASLD Highlight Positive Clinical Profile of DAA Entering Phase IIb
    6. Over 20 New Clinical Studies Presented on Masimo Noninvasive Patient Monitoring Technologies at the American Society of Anesthesiologists Annual Meeting
    7. New Analysis of CAMBIA™ Pivotal Data to be Presented at the 4th World Congress on Controversies in Neurology
    8. Positive Results From LigoCytes Norovirus Vaccine Challenge Study Presented at IDSA Annual Meeting
    9. Optimer Pharmaceuticals Announces Combined Data From Fidaxomicin Phase 3 Trials for the Treatment of Clostridium difficile Infection (CDI) Presented at IDSA
    10. Celsion Announces ThermoDoxs Prominence in Abstracts Presented at the 2nd International MR-Guided Ultrasound Symposium
    11. New FORTEO® and EVISTA® Data to be Presented at Premiere Scientific Meeting for Bone and Mineral Research
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/31/2014)... Nektar Therapeutics (Nasdaq: NKTR ) today reported its ... Cash and investments in marketable securities at ... million at March 31, 2014."The second half of 2014 will ... to significant milestones for a number of our late-stage clinical ... of Nektar. "The first of these is the potential US ...
    (Date:7/31/2014)... Conn. , July 31, 2014  UBM Medica ... a leading online community for oncologists, presents exclusive slide ... that are essential to quality cancer care. ... journal ONCOLOGY , offers news, blogs, and podcasts ... for oncologists highlighting quality cancer care: , End-of-life ...
    (Date:7/31/2014)... July 31, 2014  Decision Resources Group is launching ... product Marketrack to now include ChinaTrack; the new capabilities ... in an interactive dashboard providing detailed brand-level share tracking ... a hospital level. Other key capabilities of ... feed: In addition to end-user surveys of healthcare facilities, ...
    Breaking Medicine Technology:Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 2Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 3Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 4Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 5Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 6Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 7Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 8Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 9Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 10Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 11Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 12Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 13Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 14Cancer Network Highlights Methods Oncologists Can Use to Improve Communication 2Cancer Network Highlights Methods Oncologists Can Use to Improve Communication 3Decision Resources Group Announces First Medical Device Account Targeting Tool in China 2
    ... , , ST. LOUIS , Feb. ... that its Board of Directors declared a quarterly dividend of ... to all shareholders of record on February 15, ... and equipment used by dentists, dental hygienists, dental assistants, and ...
    ... ... the Center for Vaccine Awareness and Research at ... administered to immediate family members of newborn babies at part of ... to protect infants from the life-threatening and highly contagious pertussis (whooping ...
    Cached Medicine Technology:Young Innovations, Inc. Board of Directors Declares Quarterly Dividend 2Nation's First 'Cocoon Strategy' Vaccination Program Delivers 10,000th Immunization 2Nation's First 'Cocoon Strategy' Vaccination Program Delivers 10,000th Immunization 3Nation's First 'Cocoon Strategy' Vaccination Program Delivers 10,000th Immunization 4
    (Date:7/31/2014)... You’re having a wonderful summer—sunning, gardening, enjoying BBQs ... chills and fever, headache, stiff neck, achey joints, and a ... it could actually be the first sign of Lyme ... is greater than you might think. Until last year, it ... U.S. annually. But the Centers for Disease Control and Prevention ...
    (Date:7/31/2014)... (PRWEB) July 31, 2014 Two years ... is a in-depth overview of the research behind the ... Dietitians Brenda Davis and Vesanto Melina, well-respected authorities on ... vegan diets are safe and adequate for people at ... needs such as athletes and pregnant or lactating women. ...
    (Date:7/31/2014)... 2014 Most mommy blogs are simple ... purpose is to attract all mothers from all walks ... particular group; whether its high fashion or child rearing. ... everything on the Internet was so segmented. “I found ... particular topic and then search Google to get information ...
    (Date:7/31/2014)... 31, 2014 (HealthDay News) -- Many black women put ... new research. It,s estimated by the U.S. Centers ... five black women in the United States are overweight ... entirely to avoid having to have their hair restyled ... study authors said. However, the researchers also noted a ...
    (Date:7/31/2014)... published today in Genes & Development , ... Centre,s DNA Replication group, in collaboration with Brookhaven ... mechanisms involved in the enzyme that governs DNA ... system using synthetic, chemical and structural biology approaches, ... in duplicating genetic information embraces DNA through a ...
    Breaking Medicine News(10 mins):Health News:Feel Like You Have A Summertime 'Flu'? It Could Be Lyme Disease 2Health News:Feel Like You Have A Summertime 'Flu'? It Could Be Lyme Disease 3Health News:New Book Presents Health Professionals With A Fully-Referenced, Meticulous Overview of the Research on Plant-Based Diets As A Healthy Choice 2Health News:New Book Presents Health Professionals With A Fully-Referenced, Meticulous Overview of the Research on Plant-Based Diets As A Healthy Choice 3Health News:Mommylish Launches Its Website 2Health News:Hairdo Trumps Exercise for Many Black Women, Study Finds 2Health News:Molecular gate that could keep cancer cells locked up 2
    ... 14, 2012) A new study by University of ... for basal-like breast cancer, commonly known as triple-negative breast ... resistance to chemotherapy and occurs at women at a ... program that promotes cell migration and reduces adhesion between ...
    ... through colonoscopy is an effective treatment for recurrent ... study in Gastroenterology , the official journal of ... this study does not appear to be greater than ... itself seems to be a rather safe procedure. CDI ...
    ... large international study indicates that anti-inflammatory drugs may become ... disease (CHD), the leading global cause of death. In ... heart disease, the researchers used the Cardiochip, a gene ... researcher in the Center for Applied Genomics at The ...
    ... By Carina Storrs HealthDay Reporter , TUESDAY, March ... lot to do with factors like race, age and where ... patterns, according to a new study. Researchers analyzed food ... aged 45 and older in the continental United States, with ...
    ... Scientists have identified a new compound that rapidly kills ... liver cancer and fifth most common cancer worldwide, while ... (FQI1), works by inhibiting an oncogene originally discovered by ... Ph.D., Harrison Scholar at Virginia Commonwealth University (VCU) Massey ...
    ... 10 (HealthDay News) -- In people with a concussion, ... injury symptoms disappear, researchers have found. A test ... help improve treatment for people with a concussion, according ... led the study as a graduate student at the ...
    Cached Medicine News:Health News:New study shows promise for developing new treatments for breast cancer 2Health News:A new treatment option for Clostridium difficile: Fecal transplantation 2Health News:Gene chip invented by CHOP scientist pinpoints new target to prevent heart disease 2Health News:Race, Location Big Factors in American Diets 2Health News:Race, Location Big Factors in American Diets 3Health News:New compound discovered that rapidly kills liver cancer 2Health News:'Delayed Reactions' May Outlast Other Concussion Effects 2
    ... Reichert UNISTAT Bilirubinometer is ... for determining total bilirubin ... It quickly determines if ... needed by providing measurement ...
    Biotest ELPHA (=Enzyme Linked Probe Hybridization Assay) for class I and class II HLA typing shows convincing advantages for your lab routine....
    ... Follicle-Stimulating Hormone (FSH) is a glygoprotein produced ... such as LH, TSH, and HCG, FSH consists ... FSH is a solid phase direct sandwich ELISA ... added to the wells coated with Mab to ...
    ... Class II Direct to High Res SSP kits provide ... single tray. Locus specific typing on a single tray ... Straight from genomic DNA to high resolution results, ... level typing with a single tray , Unique reaction ...
    Medicine Products: